Bank Of Montreal 9 Meters Biopharma, Inc. Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.21 - $0.32 $3,321 - $5,061	15,817 Added 23.5%	83,123 $19,000
Q2 2022 Aug 11, 2022	BUY	$0.26 - $0.64 $1,848 - $4,551	7,111 Added 11.81%	67,306 $28,000
Q1 2022 May 12, 2022	SELL	$0.52 - $1.0 $471 - $906	-906 Reduced 1.48%	60,195 $36,000
Q4 2021 Feb 11, 2022	SELL	$0.85 - $1.33 $2,003 - $3,134	-2,357 Reduced 3.71%	61,101 $59,000
Q3 2021 Nov 12, 2021	BUY	$1.03 - $1.41 $53,359 - $73,045	51,805 Added 444.56%	63,458 $86,000
Q2 2021 Aug 12, 2021	BUY	$1.04 - $1.5 $12,119 - $17,479	11,653 New	11,653 $13,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.